How To Dose MOTS-C: Cycle, Timing & Frequency Explained

MOTS-c is a mitochondrial-derived peptide that the body produces naturally, and researchers have been studying it closely because of how it behaves during exercise and fasting. When you exercise, circulating levels of MOTS-c rise in the bloodstream, and this appears to be one of the ways the body signals cells to improve their metabolic function. Understanding that natural rhythm is actually the foundation for figuring out how to dose it correctly when using it as a peptide.

A commonly used starting point for MOTS-c is somewhere between 5 and 10 milligrams per week, and that total weekly amount is typically divided across three separate injections rather than taken all at once. The most straightforward schedule for this is Monday, Wednesday, and Friday, so the doses are spaced fairly evenly throughout the week. This approach keeps things simple and consistent, and it also reflects what the research tells us about how long MOTS-c actually stays active in the body after you introduce it.

The reason for splitting the dose across three days comes directly from exercise research, where scientists measured how long MOTS-c levels stayed elevated after physical activity. What they found is that circulating MOTS-c returns to baseline within roughly four hours after exercise, which gives you a clear picture of how short-lived the signal actually is. If someone were to take one large dose on a single day each week, that active signal would only be doing its work for a few hours out of the roughly 168 hours in a week, and the rest of the time the peptide would essentially be absent from circulation.

This matters because MOTS-c is thought to work by acting as a signaling molecule that communicates with tissues throughout the body, and those signals need a certain amount of consistency to have a meaningful effect. Spreading injections across the week helps maintain a more steady presence of the peptide in the system so more of those communication pathways stay engaged. It is a similar logic to why many hormones and peptides are dosed frequently rather than in large infrequent boluses.

Timing within the day is another important piece of the puzzle, and the recommendation to dose in the morning on an empty stomach is not arbitrary. The body naturally increases MOTS-c levels during fasting states, so morning dosing before eating is meant to work with that natural pattern rather than against it. By introducing exogenous MOTS-c during the window when the body would already be elevating its own levels, you are essentially amplifying a signal the body was already preparing to send.

There is also a practical reason to avoid dosing later in the day, and that has to do with sleep. Some people report that taking MOTS-c in the afternoon or evening disrupts their sleep quality, and because sleep is one of the most important factors for recovery and overall health, protecting it should be a priority. Taking the peptide in the morning sidesteps that issue entirely and keeps the active window of the peptide within the hours when you are awake and moving.

A lot of people who use MOTS-c also time their injection about 30 minutes before a training session, and this seems to align well with what we know about how the peptide behaves during exercise. Since exercise itself triggers a rise in MOTS-c as part of the body's mitohormetic response, dosing before training could potentially stack that exogenous signal on top of the natural exercise-induced increase. Research on mitohormesis and MOTS-c suggests this peptide plays a role in how the body adapts to metabolic stress, so timing it around exercise makes biological sense.

Mitohormesis is the process by which mild mitochondrial stress, like the kind caused by exercise, triggers beneficial adaptations in the cell. MOTS-c appears to be one of the messengers involved in that process, and some researchers think it helps coordinate how cells respond to energy demands. This connection to metabolism and mitochondrial signaling is part of why interest in MOTS-c has grown beyond just exercise science and into areas like metabolic health and aging.

Studies have also looked at MOTS-c levels in various health conditions, and some research has found that lower circulating levels of the peptide are associated with certain metabolic and autoimmune disruptions. One cross-sectional study found that people with Hashimoto's thyroiditis had reduced circulating MOTS-c, and researchers interpreted this as a reflection of broader metabolic and immune dysregulation. This kind of research helps paint a picture of MOTS-c as a biomarker and potential therapeutic target, though much of the mechanistic work is still ongoing.

Starting at the lower end of the dosing range is generally the more cautious approach, and it is the one that makes the most sense when you are introducing any new compound into your routine. Beginning with something closer to 5 milligrams per week rather than 10 gives you a chance to observe how your body responds before committing to a higher dose. Tolerance varies between individuals, and what works well for one person may not be the right starting point for another.

If you tolerate the lower dose well and feel like you want to explore more, you can gradually increase toward the higher end of the range and continue monitoring how you feel. This step-up approach reduces the risk of overshooting a dose that works for you and experiencing unwanted effects. It also gives you more useful information about your personal response because you are changing one variable at a time rather than jumping straight to a maximum dose.

The broader picture here is that MOTS-c dosing strategy is built on understanding how the peptide works in the body and trying to replicate or support those natural patterns rather than working against them. Morning dosing on an empty stomach, pre-workout timing, and spreading injections through the week all come back to the same core idea, which is that the peptide works best when it is introduced in a way that aligns with the body's own rhythms. Respecting those rhythms and starting conservatively is the approach most consistent with what the current research suggests.

---

References

1. Gusenbauer M, Haddaway NR. Which academic search systems are suitable for systematic reviews or meta-analyses? Evaluating retrieval qualities of Google Scholar, PubMed, and 26 other resources. Res Synth Methods. 2020. Source
2. Lindsey WT, Olin BR. PubMed searches: overview and strategies for clinicians. Nutr Clin Pract. 2013. Source
3. Pirani C, Camilleri J. Effectiveness of root canal filling materials and techniques for treatment of apical periodontitis: A systematic review. Int Endod J. 2023. Source
4. Shu X, Liu J, Xu B et al.. Characterization of the Avian Mitochondrial-Derived Peptide MOTS-c and Its Potential Role as a Metabolic Regulator. Animals Basel. 2025. Source
5. Sequeira IR, Woodhead JST, Chan A et al.. Plasma mitochondrial derived peptides MOTS-c and SHLP2 positively associate with android and liver fat in people without diabetes. Biochim Biophys Acta Gen Subj. 2021. Source
6. Sonay HO, Duran EN, Algemi M et al.. Reduced Circulating MOTS-c Levels in Hashimoto's Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study. J Clin Med. 2026. Source
7. Woodhead JST, Merry TL. Mitochondrial-derived peptides and exercise. Biochim Biophys Acta Gen Subj. 2021. Source
8. Yoon TK, Lee CH, Kwon O et al.. Exercise, Mitohormesis, and Mitochondrial ORF of the 12S rRNA Type-C MOTS-c. Diabetes Metab J. 2022. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness